Xenetic Biosciences, Inc. (XBIO)

Xenetic Biosciences Stock Forecast

Stock Price Forecast

There have not been any analyst price target forecasts for Xenetic Biosciences in the last 12 months.

Price Target: n/a

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	n/a	n/a	n/a	n/a
Change	n/a	n/a	n/a	n/a

Analyst Ratings

According to 1 stock analyst, the rating for Xenetic Biosciences is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	May '25	Jun '25	Jul '25	Aug '25	Sep '25	Oct '25
Strong Buy	0	0	0	0	0	0
Buy	0	0	0	0	0	0
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	1	1	1	1	1	1

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Apr 9, 2025
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Mar 20, 2025
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Dec 5, 2024
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Nov 22, 2024
Joseph Pantginis HC Wainwright & Co.	HC Wainwright & Co.	Hold Reiterates n/a	Hold	Reiterates	n/a	n/a	Aug 20, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

2.55M

Increased by 1.99%

from 2.50M

Revenue Next Year

3.06M

Increased by 20.00%

from 2.55M

EPS This Year

-2.08

from -2.57

EPS Next Year

-3.39

from -2.08

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	436.94K	1.16M	1.71M	2.54M	2.50M	2.55M	3.06M
Revenue Growth	2,460.31%	165.64%	47.06%	48.81%	-1.56%	1.99%	20.00%
EPS	-17.04	-5.49	-4.61	-2.71	-2.57	-2.08	-3.39
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	3	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	2.6M	3.2M
Avg	2.6M	3.1M
Low	2.5M	2.9M

Revenue Growth

Revenue Growth	2025	2026	2027
High	5.0%	23.5%
Avg	2.0%	20.0%
Low	-2.0%	15.3%

EPS Forecast

EPS	2025	2026	2027
High	-2.14	-3.49
Avg	-2.08	-3.39
Low	-2.00	-3.25

EPS Growth

EPS Growth	2025	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.